HAROLD E. SELICK - 26 May 2022 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Director
Signature
/s/ Asif Ali, Attorney-in-Fact for Harold E. Selick
Issuer symbol
PTGX
Transactions as of
26 May 2022
Net transactions value
$0
Form type
4
Filing time
27 May 2022, 16:00:57 UTC
Previous filing
04 Jun 2021
Next filing
06 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 26 May 2022 Common Stock 20,000 $8.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in full on the earlier of (i) May 26, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Issuer through such date.